急性A型主动脉夹层术后需VA-ECMO支持者的预测因素与结局
该多中心回顾性队列研究纳入5个欧洲中心117例急性A型主动脉夹层术后接受VA-ECMO支持的患者,30天死亡率为72%,多器官衰竭是主要早期死因,20%患者出院。ECMO前乳酸峰值、术前休克和需全弓置换与30天死亡率相关,乳酸峰值是有效预测因子。
要点
- 急性A型主动脉夹层术后需VA-ECMO支持者30天死亡率高达72%,出院率仅20%。
- ECMO前乳酸峰值、术前休克和需全弓置换与30天死亡风险独立相关。
- ECMO前乳酸峰值是30天死亡的有效预测因子,阈值85 mg/dl以上风险增加。
核心结论
- VA-ECMO支持在此类患者中可能并非徒劳,但需权衡其高风险特征。
- ECMO前乳酸峰值是30天死亡的独立危险因素和有效预测因子。
研究设计与样本
- 多中心回顾性队列研究,纳入5个欧洲中心117例急性A型主动脉夹层术后接受VA-ECMO支持的患者。
- 采用多变量二元逻辑回归分析识别30天死亡危险因素,并用ROC曲线和限制性立方样条分析ECMO前乳酸峰值与生存的关系。
主要发现
- 平均ECMO支持时间3天(四分位距1-7天),36例(31%)成功脱离ECMO。
- 30天死亡率为72%,主要早期死因为多器官衰竭(39%)。
- 20%患者出院。
- ECMO前乳酸峰值(OR 1.02,95%CI 1.005-1.032)、术前休克(OR 9.47,95%CI 1.749-98.257)和需全弓置换(OR 6.628,95%CI 1.492-33.373)与30天死亡相关。
- ECMO前乳酸峰值的AUC为0.73,限制性立方样条显示与生存显著相关(P=0.004),乳酸水平85 mg/dl以上风险增加。
临床怎么用
- 对于急性A型主动脉夹层术后需VA-ECMO支持的患者,应评估ECMO前乳酸峰值、术前休克和全弓置换等高风险因素。
- ECMO前乳酸峰值可用于风险分层,指导临床决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The study's aim was to investigate the outcomes and risk factors for mortality in patients undergoing surgery for acute type A aortic dissection receiving concomitant venoarterial extracorporeal membrane oxygenation (ECMO) support. METHODS: Patients from 5 European centre who underwent surgery for acute type A aortic dissection and received perioperative venoarterial ECMO support were included. A multivariable binary logistic regression analysis was performed to identify risk factors for 30-day mortality. A receiver operating characteristic curve and restricted cubic splines were designed to investigate the association between pre-ECMO lactate peak and survival. RESULTS: The final cohort comprised 117 patients. Mean time on ECMO support was 3 days (interquartile range 1-7). In 36 patients (31%), successful ECMO weaning was achieved. Thirty-day mortality was 72%, leading cause for early mortality was multiorgan failure (39%). In total, 20% of patients were discharged from hospital. Pre-ECMO lactate peak [odds ratio (OR) 1.02, 95% confidence interval (CI) 1.005-1.032], presence of preoperative shock (OR 9.47, 95% CI 1.749-98.257) and need for total arch replacement (OR 6.628, 95% CI 1.492-33.373) were identified as associates for 30-day mortality. For pre-ECMO lactate peak, the area under the curve showed an acceptable value of 0.73 and restricted cubic splines showed a significant correlation to survival (P = 0.004) with an increased risk above a lactate level of 85 mg/dl. CONCLUSIONS: Venoarterial ECMO support may not be futile but should be well balanced against the high-risk profile in this patient cohort. The pre-ECMO lactate peak is an independent risk factor and a valid predictor of 30-day mortality.
引用
- Pitts L, Gasser S, Uzdenov M, et al. Predictors and outcomes in patients undergoing surgery for acute type A aortic dissection requiring concomitant venoarterial extracorporeal membrane oxygenation support-a retrospective multicentre cohort study. Eur J Cardiothorac Surg. 2025. PMID: 39786547. doi:10.1093/ejcts/ezae467
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。